Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 2/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.48 |
| ▸ | GAA | P10253 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 3/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 3/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.40 |
| ▸ | SAT1 | P21673 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | GLA | P06280 | 1/20 | 0.40 |
| ▸ | DRD2 | P14416 | 2/20 | 0.39 |
| ▸ | DRD4 | P21917 | 2/20 | 0.39 |
| ▸ | DRD3 | P35462 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6223853 | 0.94 | ALDH1A1 (0.46) | MAPK1CYP2C19CYP1A2CYP2D6ALDH1A1 | |
| SCHEMBL25075398 | 0.90 | KDM4E (0.46) | MAPK1CYP2C19CYP1A2CYP2D6ALDH1A1 | |
| SCHEMBL8310112 | 0.89 | — | — | |
| SCHEMBL1796245 | 0.89 | — | — | |
| SCHEMBL5933722 | 0.89 | MAPK1 (0.43) | MAPK1CYP2C19CYP1A2CYP2D6ALDH1A1 | |
| SCHEMBL5933233 | 0.89 | MAPK1 (0.43) | MAPK1CYP2C19CYP1A2CYP2D6ALDH1A1 | |
| SCHEMBL12721326 | 0.89 | TSHR (0.52) | MAPK1CYP2C19CYP1A2CYP2D6ALDH1A1 | |
| SCHEMBL7067353 | 0.88 | KDM4E (0.44) | MAPK1CYP2C19CYP1A2CYP2D6ALDH1A1 | |
| SCHEMBL8310094 | 0.87 | — | — | |
| SCHEMBL12142926 | 0.87 | MAPK1 (0.42) | MAPK1CYP2C19CYP1A2CYP2D6ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 110 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117209385-B | Preparation method of bis (3-methoxypropyl) methylamine | 安徽恒光聚氨酯材料有限公司 | 2025-05-02 | — | — | CN | claimed |
| CN-117209385-A | Preparation method of bis (3-methoxypropyl) methylamine | 安徽恒光聚氨酯材料有限公司 | 2023-12-12 | — | — | CN | claimed |
| US-4496613-A | BINDER IS 1,3-BUTADIENE POLYMER WITH QUATERNARY AMMONIUM GROUPS | CHEMISCHE WERKE HULS AG (DE) | 1985-01-29 | — | — | US | claimed |
| US-4490176-A | PRINTING INKS, PAINTS; PIGMENT, ALKYLBENZENE SULFONIC ACID, HYDROXYNAPHTHALENE | BASF AKTIENGESELLSCHAFT (DE) | 1984-12-25 | — | — | US | claimed |
| EP-0076995-B1 | LIQUID STABLE PREPARATIONS AND THEIR USE | BASF Aktiengesellschaft (DE) | 1984-07-11 | — | — | EP | claimed |
| EP-0043932-B1 | LIQUID, STABLE PREPARATIONS OF PHTHALOCYANINE PIGMENTS OR INDANTHRON AND THEIR USE | BASF Aktiengesellschaft (DE) | 1984-04-18 | — | — | EP | claimed |
| EP-0076995-A1 | Liquid stable preparations and their use | BASF Aktiengesellschaft (DE) | 1983-04-20 | — | — | EP | claimed |
| US-4350534-A | Fluid, stable formulations of copper phthalocyanine or indanthrone | BASF AKTIENGESELLSCHAFT (DE) | 1982-09-21 | — | — | US | claimed |
| EP-0043932-A1 | Liquid, stable preparations of phthalocyanine pigments or indanthron and their use | BASF Aktiengesellschaft (DE) | 1982-01-20 | — | — | EP | claimed |
| US-20260001846-A1 | SPIROCYCLOHEXANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS ANTI-APOPTOTIC INHIBITORS | SERVIER LAB (FR) | 2026-01-01 | — | — | US | disclosed |
| EP-4663629-A1 | FLUORINATED PYRAZOLONE COMPOUND AND METHOD FOR PRODUCING SAME | Unimatec Co., Ltd. (JP) | 2025-12-17 | — | — | EP | disclosed |
| US-20250157808-A1 | METHODS AND APPARATUS UTILIZING INDIUM-BASED PRECURSORS FOR INTEGRATED CIRCUIT MANUFACTURING | INTEL CORPORATION | 2025-05-15 | — | — | US | disclosed |
| EP-4553577-A2 | METHODS AND APPARATUS UTILIZING INDIUM-BASED PRECURSORS FOR INTEGRATED CIRCUIT MANUFACTURING | INTEL Corporation (US) | 2025-05-14 | — | — | EP | disclosed |
| EP-4551566-A1 | NEW SPIROCYCLOHEXANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS ANTI-APOPTOTIC INHIBITORS | Les Laboratoires Servier (FR) | 2025-05-14 | — | — | EP | disclosed |
| US-4350534-A | Fluid, stable formulations of copper phthalocyanine or indanthrone | BASF AKTIENGESELLSCHAFT (DE) | 1982-09-21 | — | — | US | disclosed |
| EP-0043932-A1 | Liquid, stable preparations of phthalocyanine pigments or indanthron and their use | BASF Aktiengesellschaft (DE) | 1982-01-20 | — | — | EP | disclosed |
| US-4134842-A | Molded plastic bearing assembly | KAMATICS CORPORATION (US) | 1979-01-16 | — | — | US | disclosed |
| US-4053665-A | MOLDED PLASTIC BEARING ASSEMBLY | KAMATICS CORPORATION (US) | 1977-10-11 | — | — | US | disclosed |
| US-4048370-A | Shaped bearing member | KAMATICS CORPORATION (US) | 1977-09-13 | — | — | US | disclosed |
| US-3996143-A | Cured acrylate bearing member | KAMATICS CORPORATION (US) | 1976-12-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260001846-A1 | SPIROCYCLOHEXANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS ANTI-APOPTOTIC INHIBITORS | BCL2, BCL2A1, BAX | MAPK1 245/4885CYP2C19 3314/4885CYP1A2 2158/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.